Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2020

Open Access 01-12-2020 | Cystic Fibrosis | Research article

Current infection control practices used in Australian and New Zealand cystic fibrosis centers

Authors: Rebecca Elizabeth Stockwell, Michelle ELizabeth Wood, Emma Ballard, Vanessa Moore, Claire Elizabeth Wainwright, Scott Cameron Bell

Published in: BMC Pulmonary Medicine | Issue 1/2020

Login to get access

Abstract

Background

The 2013 update of the Infection Prevention and Control (IP&C) Guideline outlined recommendations to prevent the spread of CF respiratory pathogens. We aimed to investigate the current infection control practices used in Australian and New Zealand (NZ) CF centers.

Methods

Two online surveys were distributed to Australian and NZ CF centers regarding the uptake of selected IP&C recommendations. One survey was distributed to all the Medical Directors and Lead CF Nurses and the second survey was distributed to all the Lead CF Physiotherapists.

Results

The response rate was 60% (60/100) for medical/nursing and 58% (14/24) for physiotherapy. Over 90% (55/60) of CF centers followed CF-specific infection control guidelines and consistent infection control practices were seen in most CF centers; 76% (41/54) had implemented segregation strategies for ambulatory care and no CF centers housed people with CF in shared inpatient accommodation. However, the application of contact precautions (wearing gloves and apron/gown) by healthcare professionals when reviewing a CF person was variable between CF center respondents but was most often used when seeing CF persons with MRSA infection in both ambulatory care and hospital admission (20/50, 40% and 42/45, 93% of CF centers, respectively). Mask wearing by people with CF was implemented into 61% (36/59) of centers. Hospital rooms were cleaned daily in 79% (37/47) of CF centers and the ambulatory care consult rooms were always cleaned between consults (49/49, 100%) and at the end of the clinic session (51/51, 100%); however the staff member tasked with cleaning changed with 37% (18/49) of CF centers responding that CF multidisciplinary team (MDT) members cleaned between patients whereas at the end of the clinic session, only 12% (6/51) of the CF MDT cleaned the consult room.

Conclusions

Overall, Australian and NZ CF centers have adopted many recommendations from the IP&C. Although, the application of contact precautions was inconsistent and had overall a low level of adoption in CF centers. In ~ 25% of centers, mixed waiting areas occurred in the ambulatory care. Given the variability of responses, additional work is required to achieve greater consistency between centers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Saiman L, Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol. 2003;24(Suppl 5):S6–52.CrossRef Saiman L, Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol. 2003;24(Suppl 5):S6–52.CrossRef
2.
go back to reference Saiman L, Siegel JD, LiPuma JJ, Brown RF, Bryson EA, Chambers MJ, Downer VS, Fliege J, Hazle LA, et al. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol. 2014;35(Suppl 1):S1–S67.CrossRef Saiman L, Siegel JD, LiPuma JJ, Brown RF, Bryson EA, Chambers MJ, Downer VS, Fliege J, Hazle LA, et al. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol. 2014;35(Suppl 1):S1–S67.CrossRef
3.
go back to reference Jain M, Saiman LM, Sabadosa K, LiPuma JJ. Point: does the risk of cross infection warrant exclusion of adults with cystic fibrosis from cystic fibrosis foundation events? Yes. Chest. 2014;145(4):678–80.CrossRef Jain M, Saiman LM, Sabadosa K, LiPuma JJ. Point: does the risk of cross infection warrant exclusion of adults with cystic fibrosis from cystic fibrosis foundation events? Yes. Chest. 2014;145(4):678–80.CrossRef
4.
go back to reference Shepherd SL, Goodrich EJ, Desch J, Quinton PM. Counterpoint: does the risk of cross infection warrant exclusion of adults with cystic fibrosis from cystic fibrosis foundation events? No. Chest. 2014;145(4):680–3.CrossRef Shepherd SL, Goodrich EJ, Desch J, Quinton PM. Counterpoint: does the risk of cross infection warrant exclusion of adults with cystic fibrosis from cystic fibrosis foundation events? No. Chest. 2014;145(4):680–3.CrossRef
5.
go back to reference Saiman L, Zhou JJ, Jiang X, Kosorok MR, Muhlebach MS. Surveying cystic fibrosis care centers to assess adoption of infection prevention and control recommendations. Infect Control Hosp Epidemiol. 2018;39(6):647–51.CrossRef Saiman L, Zhou JJ, Jiang X, Kosorok MR, Muhlebach MS. Surveying cystic fibrosis care centers to assess adoption of infection prevention and control recommendations. Infect Control Hosp Epidemiol. 2018;39(6):647–51.CrossRef
6.
go back to reference Ruseckaite R, Ahern S, Ranger T, Tacey M, Dean J, Gardam M, Bell S, Burke N. Australian Cystic Firbosis Data Registry. In: The Australian Cystic Fibrosis Data Registry Annual Report, 2016; 2018. Ruseckaite R, Ahern S, Ranger T, Tacey M, Dean J, Gardam M, Bell S, Burke N. Australian Cystic Firbosis Data Registry. In: The Australian Cystic Fibrosis Data Registry Annual Report, 2016; 2018.
8.
go back to reference Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10 Suppl 2):S65–164.CrossRef Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10 Suppl 2):S65–164.CrossRef
11.
go back to reference Kevat A, Carzino R, Massie J, Harrison J, Griffiths AL. Elimination of Australian epidemic strain (AES1) Pseudomonas aeruginosa in a pediatric cystic fibrosis center. Pediatr Pulmonol. 2018;53(11):1498–503.CrossRef Kevat A, Carzino R, Massie J, Harrison J, Griffiths AL. Elimination of Australian epidemic strain (AES1) Pseudomonas aeruginosa in a pediatric cystic fibrosis center. Pediatr Pulmonol. 2018;53(11):1498–503.CrossRef
12.
go back to reference van Mansfeld R, de Vrankrijker A, Brimicombe R, Heijerman H, Teding van Berkhout F, Spitoni C, Grave S, van der Ent C, Wolfs T, et al. The effect of strict segregation on Pseudomonas aeruginosa in cystic fibrosis patients. PLoS One. 2016;11(6):e0157189.CrossRef van Mansfeld R, de Vrankrijker A, Brimicombe R, Heijerman H, Teding van Berkhout F, Spitoni C, Grave S, van der Ent C, Wolfs T, et al. The effect of strict segregation on Pseudomonas aeruginosa in cystic fibrosis patients. PLoS One. 2016;11(6):e0157189.CrossRef
13.
go back to reference Griffiths AL, Wurzel DF, Robinson PJ, Carzino R, Massie J. Australian epidemic strain Pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic. J Cyst Fibros. 2012;11(1):49–52.CrossRef Griffiths AL, Wurzel DF, Robinson PJ, Carzino R, Massie J. Australian epidemic strain Pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic. J Cyst Fibros. 2012;11(1):49–52.CrossRef
14.
go back to reference Griffiths AL, Jamsen K, Carlin JB, Grimwood K, Carzino R, Robinson PJ, Massie J, Armstrong DS. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med. 2005;171(9):1020–5.CrossRef Griffiths AL, Jamsen K, Carlin JB, Grimwood K, Carzino R, Robinson PJ, Massie J, Armstrong DS. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med. 2005;171(9):1020–5.CrossRef
16.
go back to reference Stockwell RE, Wood ME, He C, Sherrard LJ, Ballard EL, Kidd TJ, Johnson GR, Knibbs LD, Morawska L, et al. Face masks reduce the release of Pseudomonas aeruginosa cough aerosols when worn for clinically relevant periods. Am J Respir Crit Care Med. 2018;198(10):1339–42.CrossRef Stockwell RE, Wood ME, He C, Sherrard LJ, Ballard EL, Kidd TJ, Johnson GR, Knibbs LD, Morawska L, et al. Face masks reduce the release of Pseudomonas aeruginosa cough aerosols when worn for clinically relevant periods. Am J Respir Crit Care Med. 2018;198(10):1339–42.CrossRef
17.
go back to reference Wood ME, Stockwell RE, Johnson GR, Ramsay KA, Sherrard LJ, Jabbour N, Ballard E, O'Rourke P, Kidd TJ, et al. Face masks and cough etiquette reduce the cough aerosol concentration of Pseudomonas aeruginosa in people with cystic fibrosis. Am J Respir Crit Care Med. 2018;197(3):348–55.CrossRef Wood ME, Stockwell RE, Johnson GR, Ramsay KA, Sherrard LJ, Jabbour N, Ballard E, O'Rourke P, Kidd TJ, et al. Face masks and cough etiquette reduce the cough aerosol concentration of Pseudomonas aeruginosa in people with cystic fibrosis. Am J Respir Crit Care Med. 2018;197(3):348–55.CrossRef
18.
go back to reference Barker AK, Alagoz O, Safdar N. Interventions to reduce the incidence of hospital-onset Clostridium difficile infection: an agent-based modeling approach to evaluate clinical effectiveness in adult acute care hospitals. Clin Infect Dis. 2018;66(8):1192–203.CrossRef Barker AK, Alagoz O, Safdar N. Interventions to reduce the incidence of hospital-onset Clostridium difficile infection: an agent-based modeling approach to evaluate clinical effectiveness in adult acute care hospitals. Clin Infect Dis. 2018;66(8):1192–203.CrossRef
19.
go back to reference Sitzlar B, Deshpande A, Fertelli D, Kundrapu S, Sethi AK, Donskey CJ. An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms. Infect Control Hosp Epidemiol. 2013;34(5):459–65.CrossRef Sitzlar B, Deshpande A, Fertelli D, Kundrapu S, Sethi AK, Donskey CJ. An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms. Infect Control Hosp Epidemiol. 2013;34(5):459–65.CrossRef
20.
go back to reference Hess AS, Shardell M, Johnson JK, Thom KA, Roghmann MC, Netzer G, Amr S, Morgan DJ, Harris AD. A randomized controlled trial of enhanced cleaning to reduce contamination of healthcare worker gowns and gloves with multidrug-resistant bacteria. Infect Control Hosp Epidemiol. 2013;34(5):487–93.CrossRef Hess AS, Shardell M, Johnson JK, Thom KA, Roghmann MC, Netzer G, Amr S, Morgan DJ, Harris AD. A randomized controlled trial of enhanced cleaning to reduce contamination of healthcare worker gowns and gloves with multidrug-resistant bacteria. Infect Control Hosp Epidemiol. 2013;34(5):487–93.CrossRef
21.
go back to reference Hefzy EM, Wegdan AA, Abdel Wahed WY. Hospital outpatient clinics as a potential hazard for healthcare associated infections. J Infect Public Health. 2016;9(1):88–97.CrossRef Hefzy EM, Wegdan AA, Abdel Wahed WY. Hospital outpatient clinics as a potential hazard for healthcare associated infections. J Infect Public Health. 2016;9(1):88–97.CrossRef
23.
go back to reference Miroballi Y, Garber E, Jia H, Zhou JJ, Alba L, Quittell LM, Angst D, Cabana M, Saiman L. Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families. Pediatr Pulmonol. 2012;47(2):144–52.CrossRef Miroballi Y, Garber E, Jia H, Zhou JJ, Alba L, Quittell LM, Angst D, Cabana M, Saiman L. Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families. Pediatr Pulmonol. 2012;47(2):144–52.CrossRef
24.
go back to reference Palser SC, Rayner OC, Leighton PA, Smyth AR. Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study. BMJ Open. 2016;6(12):e012303.CrossRef Palser SC, Rayner OC, Leighton PA, Smyth AR. Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study. BMJ Open. 2016;6(12):e012303.CrossRef
25.
go back to reference Shearing V, Duff AJ, Denton M. Mycobacterium abscessus in people with cystic fibrosis: considerations for psychosocial care. Lancet Respir Med. 2015;3(11):832–4.CrossRef Shearing V, Duff AJ, Denton M. Mycobacterium abscessus in people with cystic fibrosis: considerations for psychosocial care. Lancet Respir Med. 2015;3(11):832–4.CrossRef
26.
go back to reference Russo K, Donnelly M, Reid AJ. Segregation - the perspectives of young patients and their parents. J Cyst Fibros. 2006;5(2):93–9.CrossRef Russo K, Donnelly M, Reid AJ. Segregation - the perspectives of young patients and their parents. J Cyst Fibros. 2006;5(2):93–9.CrossRef
27.
go back to reference Griffiths AL, Armstrong D, Carzino R, Robinson P. Cystic fibrosis patients and families support cross-infection measures. Eur Respir J. 2004;24(3):449–52.CrossRef Griffiths AL, Armstrong D, Carzino R, Robinson P. Cystic fibrosis patients and families support cross-infection measures. Eur Respir J. 2004;24(3):449–52.CrossRef
28.
go back to reference Fincham JE. Response rates and responsiveness for surveys, standards, and the journal. Am J Pharm Educ. 2008;72(2):43.CrossRef Fincham JE. Response rates and responsiveness for surveys, standards, and the journal. Am J Pharm Educ. 2008;72(2):43.CrossRef
Metadata
Title
Current infection control practices used in Australian and New Zealand cystic fibrosis centers
Authors
Rebecca Elizabeth Stockwell
Michelle ELizabeth Wood
Emma Ballard
Vanessa Moore
Claire Elizabeth Wainwright
Scott Cameron Bell
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2020
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-020-1052-y

Other articles of this Issue 1/2020

BMC Pulmonary Medicine 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.